195 related articles for article (PubMed ID: 4703858)
1. [Inter-individual differences in pharmacokinetics in humans: clinical importance].
Sjöqvist F
Minerva Med; 1973 Mar; 64(17):866-79. PubMed ID: 4703858
[No Abstract] [Full Text] [Related]
2. [Differences between individuals in human pharmacokinetics. Clinical significance].
Sjöqvist F
Munch Med Wochenschr; 1972 Sep; 114(38):1600-8. PubMed ID: 4678410
[No Abstract] [Full Text] [Related]
3. Interindividual differences in drug oxidation: clinical importance.
Sjöqvist F; von Bahr C
Drug Metab Dispos; 1973; 1(1):469-82. PubMed ID: 4149420
[No Abstract] [Full Text] [Related]
4. Interindividual differences in pharmacokinetics in man: clinical importance.
Sjöqvist F
Panminerva Med; 1973 Apr; 15(4):99-112. PubMed ID: 4808047
[No Abstract] [Full Text] [Related]
5. Practical pharmacokinetics as part of clinical pharmacology.
Gladtke E
Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):37-41. PubMed ID: 4924326
[No Abstract] [Full Text] [Related]
6. Individual differences in the disposition of drugs metabolised in the body.
Alvan G
Clin Pharmacokinet; 1978; 3(2):155-75. PubMed ID: 346288
[No Abstract] [Full Text] [Related]
7. [Clinical pharmacology: clinical pharmacokinetics in patient care].
Sjöqvist F
Lakartidningen; 1970 Apr; 67(18):2036-42. PubMed ID: 5450543
[No Abstract] [Full Text] [Related]
8. Editorial: Drug metabolism in disease.
Lancet; 1974 Apr; 1(7861):790-1. PubMed ID: 4132718
[No Abstract] [Full Text] [Related]
9. [The metabolic effect of drugs on their effective strength and duration].
Remmer H
Arzneimittelforschung; 1972 Feb; 22(2):292-6. PubMed ID: 5067478
[No Abstract] [Full Text] [Related]
10. Impairment of drug metabolism in man by allopurinol and nortriptyline.
Vesell ES; Passananti GT; Greene FE
N Engl J Med; 1970 Dec; 283(27):1484-8. PubMed ID: 4098480
[No Abstract] [Full Text] [Related]
11. [Pharmacokinetics as a basic pharmacological problem].
Dettli L
Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():59-73. PubMed ID: 4906026
[No Abstract] [Full Text] [Related]
12. [Individual differences in pharmacokinetics in humans (clinical importance)].
Sjöqvist F
Cah Med; 1973 Apr; 14(4):292-303. PubMed ID: 4742878
[No Abstract] [Full Text] [Related]
13. [Genetic causes for the variability of effects and side effects of drugs].
Roots I
Internist (Berl); 1982 Nov; 23(11):601-9. PubMed ID: 6759450
[No Abstract] [Full Text] [Related]
14. Pharmacogenetics.
Du BN
Med Clin North Am; 1969 Jul; 53(4):839-55. PubMed ID: 4892640
[No Abstract] [Full Text] [Related]
15. Confounding factors for sex differences in pharmacokinetics and pharmacodynamics: focus on dosing regimen, dosage form, and formulation.
Chen ML
Clin Pharmacol Ther; 2005 Oct; 78(4):322-9. PubMed ID: 16198651
[No Abstract] [Full Text] [Related]
16. The importance of stable isotope labelled drugs in clinical pharmacology: with illustrations from studies on the disposition of propranolol and nortriptyline in man.
Gaffney TE; Knapp D; Walle T; Privitera P; Saelens D
South Med J; 1974 Aug; 67(8):990-1002. PubMed ID: 4854875
[No Abstract] [Full Text] [Related]
17. [Basic directives in genetic studies in pharmacology].
Mkheidze MO
Klin Med (Mosk); 1974 Oct; 52(10):74-9. PubMed ID: 4437077
[No Abstract] [Full Text] [Related]
18. Drugs, vitamins, and gender.
Berg MJ
J Gend Specif Med; 1998 Sep; 1(1):10-1. PubMed ID: 11279846
[No Abstract] [Full Text] [Related]
19. Metabolism and pharmacokinetics in children and the elderly.
Pelkonen O
Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):147-8. PubMed ID: 17428146
[TBL] [Abstract][Full Text] [Related]
20. Why can't a woman be more like a man?
Gray J
Clin Pharmacol Ther; 2007 Jul; 82(1):15-7. PubMed ID: 17571069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
